Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/114573
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Large-scale production of lentiviral vectors using multilayer cell factories
Author: Rout-Pitt, N.
McCarron, A.
McIntyre, C.
Parsons, D.
Donnelley, M.
Citation: Journal of Biological Methods, 2018; 5(2):e90-1-e90-9
Publisher: POL Scientific
Issue Date: 2018
ISSN: 2326-9901
2326-9901
Statement of
Responsibility: 
Nathan Rout-Pitt, Alexandra McCarron, Chantelle McIntyre, David Parsons, Martin Donnelley
Abstract: Lentiviral-mediated gene therapy has been proposed for the treatment of a range of diseases, and due to its genome integration properties, it offers the potential for long-lasting benefit from a once-off treatment. Production methods for pre-clinical studies in animal models, and ultimately for human clinical trials, must be capable of producing large quantities of high-quality lentiviral vector in an efficient and cost-effective manner. We report here a medium-scale method (from 1.5 L to 6 L of vector supernatant) for lentiviral vector production in adherent cell cultures using the NUNC™ EasyFill™ Cell Factory™ from Thermo Fisher Scientific. Downstream purification uses a Mustang Q XT5 anion exchange capsule from Pall, and an ultracentrifugation step to concentrate the vector. This method is capable of producing lentiviral vector with concentrated titres of 108–109 TU/ml, with reduced manual handling compared to single monolayer flask methods.
Keywords: Calcium phosphate; cell factories; lentiviral vector; Mustang Q; ultracentrifugation
Rights: © The Authors. This work is licensed under a Creative Commons Attribution 3.0 License.
RMID: 0030084920
DOI: 10.14440/jbm.2018.236
Grant ID: http://purl.org/au-research/grants/nhmrc/1098127
Appears in Collections:IPAS publications
Medicine publications

Files in This Item:
File Description SizeFormat 
hdl_114573.pdfPublished Version1.31 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.